Viz.ai Names Jieun Choe Chief Marketing Officer
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has named life sciences veteran Jieun Choe as chief...
Oct 25, 2022
All Resources
Explore our latest resources
Viz.ai Receives FDA 510(k) Clearance for Automated RV/LV Analysis Algorithm
Part of the Viz PE Solution, new algorithm flags key patient risk indicator of pulmonary embolism severity. SAN FRANCISCO – September...
Sep 01, 2022
Making Moves at Vascular Events this Summer
The Viz.ai team has been busy this summer attending several vascular events, meeting with clinical leaders advancing the vascular surgery...
Aug 24, 2022
Viz.ai Receives FDA 510(k) Clearance for Viz™ SUBDURAL (SDH)
AI-powered Viz SUBDURAL (SDH) automatically detects subdural hemorrhage, enables effective triage and optimal care SAN FRANCISCO - July 27, 2022...
Jul 27, 2022
Viz.ai Partners with Hyperfine to Enable New MR Imaging and Workflow Paradigm
Viz.ai announced today it is partnering with Hyperfine, Inc., creator of the first FDA-cleared point-of-care magnetic resonance imaging (MRI) device,...
Jul 26, 2022
Contrast Shortage: How to move forward and continue to provide the best patient...
Explore imaging trends in the acute stroke setting across 1000 hospitals in the US to understand the impact of the...
Jul 13, 2022
